Amarantus commences launch of proprietary Alzheimer's blood diagnostic LymPro Test(R)
Amarantus announced launch of the company's LymPro Test®, a leading, proprietary Alzheimer's blood diagnostic, to the pharma industry for investigational use in clinical development programs. The commercialization follows successful completion of the requisite 'Fit-for-Purpose' assay validation. December 22, 2014